Literature DB >> 4005157

Harlequin fetus successfully treated with etretinate.

F Lawlor, S Peiris.   

Abstract

A harlequin fetus seen at birth was treated with etretinate and more general measures, including careful attention to fluid balance, calorie intake and temperature control. She improved, continued to develop, and had survived to 5 months at the time of this report.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4005157     DOI： 10.1111/j.1365-2133.1985.tb15268.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  5 in total

1.  Successful treatment of a harlequin fetus.

Authors:  P S Ward; R D Jones
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

2.  Etretinate in the management of harlequin siblings.

Authors:  R K Pejaver; R S Prasad; A K Garg; A Jelly; S Shawkat
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

3.  Self-improvement of keratinocyte differentiation defects during skin maturation in ABCA12-deficient harlequin ichthyosis model mice.

Authors:  Teruki Yanagi; Masashi Akiyama; Hiroshi Nishihara; Junko Ishikawa; Kaori Sakai; Yuki Miyamura; Ayano Naoe; Takashi Kitahara; Shinya Tanaka; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

4.  Harlequin ichthyosis (ichq): a juvenile lethal mouse mutation with ichthyosiform dermatitis.

Authors:  J P Sundberg; D Boggess; M E Hogan; B A Sundberg; M H Rourk; B Harris; K Johnson; R W Dunstan; M T Davisson
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

5.  Progress of a harlequin fetus treated with etretinate.

Authors:  F Lawlor; S Peiris
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.